Histone post-translational modifications (PTMs) are key determinants of the local chromatin landscape and critical for regulation of eukaryotic gene expression. These histone marks are deposited by a vast number of chromatin modifying enzymes and preferentially recognized by specific associated histone reader domains. Recognition of histone PTMs by histone reader domains is important for either targeting these complexes to chromatin or regulating their enzymatic activity once there. The Polycomb repressive complex 1 and 2 (PRC1 and PRC2) are two such chromatin modifying complexes that are critical for developmental gene repression. The enzymatic activity of PRC2 is tightly regulated by many histone reader domains whereas the PRC1 complex is targeted to chromatin through these domains. In this thesis, I explore how PRC1 and PRC2 functions are regulated by histone reader domains. I identify a previously unrecognized histone reader domain within the PRC2 complex, the EZH2 SANT1 domain, which has important implications for regulating PRC2 enzymatic activity. In addition, I explore the mechanism through which the CBX8 chromodomain targets the PRC1 complex to chromatin. Together, these studies provide significant insight into the regulation of chromatin modifying complexes by histone reader domains and how this occurs via multiple mechanisms.
Regulation of the polycomb repressive complexes by histone reader domains
Abstract
Details
- Title: Subtitle
- Regulation of the polycomb repressive complexes by histone reader domains
- Creators
- Tyler M. Weaver - University of Iowa
- Contributors
- Catherine A. Musselman (Advisor)Lori L. Wallrath (Advisor)Maria Spies (Committee Member)Ernesto Fuentes (Committee Member)Pamela Geyer (Committee Member)John Manak (Committee Member)
- Resource Type
- Dissertation
- Degree Awarded
- Doctor of Philosophy (PhD), University of Iowa
- Degree in
- Biochemistry
- Date degree season
- Spring 2019
- DOI
- 10.17077/etd.57vs-1bvo
- Publisher
- University of Iowa
- Number of pages
- xi, 166 pages
- Copyright
- Copyright © 2019 Tyler M. Weaver
- Comment
This thesis has been optimized for improved web viewing. If you require the original version, contact the University Archives at the University of Iowa: https://www.lib.uiowa.edu/sc/contact/.
- Language
- English
- Date submitted
- 11/06/2019
- Description illustrations
- color illustrations
- Description bibliographic
- Includes bibliographical references (pages 156-166).
- Public Abstract (ETD)
Every cell in the human body contains the same genomic DNA, containing approximately 20,000 genes, which must give rise to all of the different cell types we have. For example, skin cells and brain cells contain the same genomic DNA, but these cells are vastly different in their structure and function. The different structure and function of these cell types arise from the ability to turn certain genes on and off in a spatial and temporal manner. One way to regulate whether a gene is on or off is the presence of proteins, known as histones, which wrap up our genomic DNA into a fundamental repeating unit known as the nucleosome. These nucleosomes can be modified, moved or removed from DNA by large protein complexes which serves to turn genes on or off. How these protein complexes interact with nucleosomes, which genes containing nucleosomes they go to and how the modify nucleosomes is currently under intense research.
The Polycomb repressive complexes (PRC1 and PRC2) are two protein complexes that are important for turning genes off as precursor cells develop into different cell types. How these protein complexes are brought to certain genes for repression and how they modify chromatin is still an active area of research. My work identifies specific regions of two proteins in the PRC1 and PRC2 that are important for the interaction with the nucleosomes, deciding what genes they go to in the cell and how they affect the complexes ability to modify chromatin. Importantly, these two complexes have been implicated in disease states such as cancer and many others, which have made them highly valuable targets for drug development. Together, my work enhances our knowledge of how these two protein complexes work to repress genes and provides a framework for the development of drugs to treat disease states when there function becomes altered.
- Academic Unit
- Craniofacial Anomalies Research Center; Biochemistry and Molecular Biology
- Record Identifier
- 9983777168302771